Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CSBR compared with MRKR: revenue, margins and what each company keeps, and the suppliers and customers both name
CSBR
Champions Oncology, Inc.
Change
Mkt cap
Revenue
Revenue
MRKR
Marker Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CSBR
Champions Oncology, Inc.
vs
MRKR
Marker Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
CSBR
2 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Sep 11 '26
±51.5%
▲
+0.09%
×0.00
Q1 FY27
—
▼
−8.75%
—
MRKR
No earnings history for MRKR.
= implied
CSBR realized, solid
MRKR realized, hatched
One scale, both sides: full bar = 52%
× = |realized| ÷ implied
Source: market data
CSBR
Champions Oncology, Inc.
Change
4.80
▲
+0.84%
· post 4.80
Mkt cap
$66.7M
Revenue
$15M
Q1 FY27
Revenue
$59M
FY26
MRKR
Marker Therapeutics, Inc.
Change
0.91
▲
+2.00%
· post 0.91
Closed
Nov 6 '26
Mkt cap
$14.9M
Revenue
$1M
Q4 FY25
Revenue
$7M
FY24
vs
Compare
Closed
Nov 6 '26
CSBR
Champions Oncology, Inc.
vs
MRKR
Marker Therapeutics, Inc.
4.80
▲
+0.84%
post 4.80
Price
0.91
▲
+2.00%
post 0.91
$66.7M
Mkt cap
$14.9M
Q1 FY27
$15M
Revenue
$1M
Q4 FY25
FY26
$59M
Revenue
$7M
FY24
Change
Change
CSBR
4.80
▲
+0.84%
vs
MRKR
0.91
▲
+2.00%
Closed
Nov 6 '26